Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Novel acylguanidine-based small molecule inhibits HIV-1 replication

March 10, 2015

Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation

March 9, 2015

CTX conditioning maximizes SB-728-T engraftment

March 5, 2015

Envelope-specific monoclonal antibodies offer a novel approach for the treatment of HIV infection

March 3, 2015

Tenofovir alafenamide fumarate subject of several presentations at CROI

March 3, 2015

Phase II data lead to phase III initiation for HIV candidate BMS-663068

March 3, 2015

Initiation of clinical trial of TLR7 agonist GS-9620 in HIV-positive patients on ART

March 3, 2015

Combination therapy shows efficiency for HIV/HCV coinfection treatment

March 2, 2015

Inhibition of HIV RNA biogenesis blocks viral replication and avoids viremia rebound

March 2, 2015

Potent antiviral activity seen with maturation inhibitor BMS-955176 in HIV-1-positive patients

Feb. 27, 2015

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...